p53, bcl-2, and Bax Expression in Renal Cell Carcinoma

This publication has 12 references indexed in Scilit:

• Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53
  International Journal of Cancer, 1996
• Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas
  British Journal of Cancer, 1996
• Detection of p53 gene alteration in renal‐cell cancer by micropreparation techniques of tumor specimens
  International Journal of Cancer, 1995
• Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosis
  The Journal of Pathology, 1995
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
  Cell, 1995
• Bcl-2 blocks p53-dependent apoptosis.
  Molecular and Cellular Biology, 1994
• Infrequent Involvement of P53 Mutations and Loss of Heterozygosity of 17p in the Tumorigenesis of Renal Cell Carcinoma
  Journal of Urology, 1993
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
  Cell, 1993
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993
• Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma
  Urology, 1992